十二指肠型滤泡性淋巴瘤的肿瘤免疫微环境
本研究分析十二指肠型滤泡性淋巴瘤(DTFL,n=30)、局限期滤泡性淋巴瘤(LSFL,n=19)和晚期滤泡性淋巴瘤(ASFL,n=31)诊断标本的肿瘤免疫微环境,发现DTFL肿瘤滤泡内CD8+肿瘤浸润淋巴细胞均值高于LSFL和ASFL,而效应调节性T细胞较少,外周血中非耗竭表型CD8+PD1- T细胞更丰富,提示增强的抗肿瘤免疫反应可能贡献于DTFL更好的预后。
要点
- DTFL肿瘤滤泡内CD8+ TIL均值1827/mm2,高于LSFL的1150/mm2和ASFL的1188/mm2(P=0.002)。
- DTFL肿瘤滤泡内FOXP3+CTLA-4+ eTreg均值12/mm2,低于LSFL的78/mm2和ASFL的109/mm2。
核心结论
- 这些结果提示,增强的抗肿瘤免疫反应可能贡献于DTFL更好的预后。
研究设计与样本
- 研究分析了DTFL(n=30)、局限期FL(LSFL;n=19)和晚期FL(ASFL;n=31)患者诊断标本的肿瘤免疫微环境。
主要发现
- 肿瘤滤泡内CD8+ TIL均值DTFL为1827/mm2,LSFL为1150/mm2,ASFL为1188/mm2(分别P=0.002、P=0.002)。
- DTFL外周血中非耗竭表型的CD8+PD1- T细胞较LSFL和ASFL更丰富。
- 肿瘤滤泡内FOXP3+CTLA-4+ eTreg均值DTFL为12/mm2,LSFL为78/mm2,ASFL为109/mm2(分别P=2.80×10-5、P=4.74×10-8)。
- 循环FOXP3hi CD45RA- CD25hi eTreg比例DTFL为0.146%,ASFL为0.497%,健康对照为0.639%(分别P=0.0003、P=6.79×10-7)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite duodenal-type follicular lymphoma (DTFL) being morphologically, immunophenotypically and genetically indistinguishable from nodal FL (nFL), this entity typically shows a significantly better prognosis. Here, we analysed the tumour immune microenvironments of diagnostic specimens from patients with DTFL (n = 30), limited-stage FL (LSFL; n = 19) and advanced-stage FL (ASFL; n = 31). The mean number of CD8+ tumour-infiltrating lymphocytes (TILs) in the neoplastic follicles was higher in DTFL (1,827/mm2 ) than in LSFL (1,150/mm2 ) and ASFL (1,188/mm2 ) (P = 0·002, P = 0·002, respectively). In addition, CD8+ PD1- T cells with non-exhausting phenotype were more abundant in the peripheral blood (PB) of DTFL than in LSFL and ASFL, indicating that DTFL may exhibit a better and longer-lasting T cell-mediated immune response. Moreover, whereas FOXP3+ CTLA-4+ effector regulatory T cells (eTregs) were rarely observed in the neoplastic follicles of DTFL (mean: 12/mm2 ), they were more abundant in LSFL (78/mm2 ) and ASFL (109/mm2 ) (P = 2·80 × 10-5 , P = 4·74 × 10-8 , respectively), and the numbers of eTregs correlated inversely with those of CD8+ TILs (r = -0267; P = 0·018). Furthermore, DTFL showed significantly fewer circulating FOXP3hi CD45RA- CD25hi eTregs (0·146%) than ASFL (0·497%) and healthy controls (0·639%) (P = 0·0003, P = 6·79 × 10-7 , respectively). These results suggest that the augmented anti-tumour immune reactions may contribute to a better prognosis on DTFL.
引用
- Inoue H, Rai S, Tanaka H, et al. Tumour-immune microenvironment in duodenal-type follicular lymphoma. Br J Haematol. 2020. PMID: 32383789. doi:10.1111/bjh.16715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。